Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Maha FDA seizes in-vitro diagnostic kits worth Rs 12.40 lakh in Thane

Ruchika Sharma5 Aug 2022 12:45 PM IST

Thane: The Food and Drugs Administration (FDA) of Maharashtra has seized in-vitro diagnostic kits which were being sold without license in Thane...

Roche, Novo Nordisk Education Foundation ink pact to enhance Type 1 Diabetes care for children in India

Ruchika Sharma5 Aug 2022 11:48 AM IST

"Support will include free diabetes monitoring and management kits including insulin pens, needles, insulin cartridges, glucometers, strips, and...

USFDA nod to Zydus Diabetes drug Empagliflozin

Ruchika Sharma4 Aug 2022 3:45 PM IST

The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.

Zydus Lifesciences bags USFDA nod for Ivermectin Cream for treatment of inflammatory lesions of rosacea

Ruchika Sharma4 Aug 2022 2:51 PM IST

Ivermectin Cream is used for the treatment of inflammatory lesions of rosacea.

Jubilant Therapeutics gets USFDA clearance for JBI-778 to treat solid tumors with brain metastases, primary brain tumors

Ruchika Sharma4 Aug 2022 1:45 PM IST

Bedminster: Jubilant Therapeutics Inc., a biopharmaceutical company has announced U.S. Food and Drug Administration (USFDA) clearance of the...

Parallel Book-keeping, Referral Payments to Doctors and Clinics: IT raid at Delhi Hospitals reveal Rs 150 crore unaccounted income

Ruchika Sharma4 Aug 2022 1:19 PM IST

New Delhi: An income tax raid at a series of hospitals and healthcare institutions in Delhi-NCR seems to have opened a can of worms...

Novavax COVID shot Nuvaxovid must carry warning of heart inflammation, recommends EU

Ruchika Sharma4 Aug 2022 12:59 PM IST

"We will work with the relevant regulators to assure our product information is consistent with our common interpretation of the incoming data," U.S....

Janssen gets USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients

Ruchika Sharma4 Aug 2022 11:46 AM IST

STELARA is administered as a subcutaneous injection dosed four times per year after two starter doses for the treatment of pediatric patients six...

Serum Institute conducting research to find vaccine against monkeypox: Adar Poonawalla

Ruchika Sharma3 Aug 2022 5:08 PM IST

Monkeypox typically manifests itself with fever, rash and swollen lymph nodes and may lead to a range of medical complications. It is usually a...

Strides Pharma Science arm bags USFDA nod for Cyclosporine Softgel Capsules

Ruchika Sharma3 Aug 2022 3:00 PM IST

The product will be manufactured at the company's facility at Bengaluru and will be marketed by Strides Pharma Inc. in the US market.

Govt panel recommends allowing Biological E Corbevax as booster for Covishield, Covaxin recipients

Ruchika Sharma3 Aug 2022 2:30 PM IST

India's first indigenously developed RBD protein subunit vaccine Corbevax is currently being used to inoculate children in the age group of 12 to 14...

Aurobindo Pharma gets 3 USFDA observations for Andhra Pradesh facility

Ruchika Sharma3 Aug 2022 1:10 PM IST

Hyderabad: Aurobindo Pharma has recently announced that the United States Food and Drug Administration (USFDA) has issued FORM 483 with 3 observations...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok